Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease

View through CrossRef
Nontuberculous mycobacteria (NTM) cause significant pulmonary infections in humans. Researchers have reported an association between interferon-gamma receptor-1 (IFN-γR1 or IFNGR1) deficiency and susceptibility to NTM, but the relevance of polymorphism within these genes is not yet clear. In this study, a single nucleotide polymorphism (SNP), T to C, at position-56 in NTM patients with pulmonary disease was investigated. Molecular identification of Mycobacterium isolates was performed with hsp65 genes using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Then, the host genomic DNA from confirmed NTM patients (N = 80) and control subjects (N = 80) were screened for SNPs of IFNGR1 (T-56C) by PCR-RFLP. The results indicated that NTM patients had higher TC (26/80; 32.5%) or CC (46/80; 57.5%) genotypes in comparison with control groups (TC genotypes [22/80, 27.5%]; CC genotypes [6/80, 7.5%]) (P < 0.05). In this regard, all the patients infected with rapid-growing Mycobacterium (RGM, i.e., Mycobacterium chelonae and Mycobacterium fortuitum) had CC genotypes (100%). In contrary, only 50.7% (35/69) of infected patients with slow-growing Mycobacterium (i.e., Mycobacterium simiae, Mycobacterium kansasii, and Mycobacterium avium-intracellulare) had CC genotypes. Thus, patients with CC mutation in IFNGR1 at position-56 are more likely to develop RGM infection. In overall, there is a significant association between SNP of IFNGR1 at position-56 and susceptibility to NTM infection. Based on these data, we propose SNP of IFNGR1 at position-56 as a suitable “biomarker” for identifying populations at higher risk of infection.
Title: Association of Interferon-γ Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease
Description:
Nontuberculous mycobacteria (NTM) cause significant pulmonary infections in humans.
Researchers have reported an association between interferon-gamma receptor-1 (IFN-γR1 or IFNGR1) deficiency and susceptibility to NTM, but the relevance of polymorphism within these genes is not yet clear.
In this study, a single nucleotide polymorphism (SNP), T to C, at position-56 in NTM patients with pulmonary disease was investigated.
Molecular identification of Mycobacterium isolates was performed with hsp65 genes using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).
Then, the host genomic DNA from confirmed NTM patients (N = 80) and control subjects (N = 80) were screened for SNPs of IFNGR1 (T-56C) by PCR-RFLP.
The results indicated that NTM patients had higher TC (26/80; 32.
5%) or CC (46/80; 57.
5%) genotypes in comparison with control groups (TC genotypes [22/80, 27.
5%]; CC genotypes [6/80, 7.
5%]) (P < 0.
05).
In this regard, all the patients infected with rapid-growing Mycobacterium (RGM, i.
e.
, Mycobacterium chelonae and Mycobacterium fortuitum) had CC genotypes (100%).
In contrary, only 50.
7% (35/69) of infected patients with slow-growing Mycobacterium (i.
e.
, Mycobacterium simiae, Mycobacterium kansasii, and Mycobacterium avium-intracellulare) had CC genotypes.
Thus, patients with CC mutation in IFNGR1 at position-56 are more likely to develop RGM infection.
In overall, there is a significant association between SNP of IFNGR1 at position-56 and susceptibility to NTM infection.
Based on these data, we propose SNP of IFNGR1 at position-56 as a suitable “biomarker” for identifying populations at higher risk of infection.

Related Results

The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Genotyping Method and Frequency of ADRB3-rs4994 Single Nucleotide Polymorphism Genotypes in Hanoi 3-5 Years Old Chidren
Genotyping Method and Frequency of ADRB3-rs4994 Single Nucleotide Polymorphism Genotypes in Hanoi 3-5 Years Old Chidren
The Trp64Arg (rs4994) polymorphism in codon 64 of ADRB3 (beta3-adrenergic receptor) gene is involved in the regulation of energy metabolism. This study optimizes the genotyping met...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Scrofuloderma and Sweet’s syndrome
Scrofuloderma and Sweet’s syndrome
AbstractBackground In recent years, the rare association of Sweet’s syndrome with nontuberculous mycobacterial lymphadenitis has been reported.Objective To report the clinical, dem...
Video-assisted thoracoscopic surgery for nontuberculous mycobacterial infection
Video-assisted thoracoscopic surgery for nontuberculous mycobacterial infection
Background The number of patients with nontuberculous mycobacterium infection is increasing in Japan, and therefore surgical treatment is also being applied wit...

Back to Top